BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  HSS Announces Leadership Successions in Specialties of Joint and Pediatric Surgery

  David J. Mayman, MD appointed Chief of Adult Reconstruction and Joint Replacement; Daniel W. Green, MD, MS named Chief of Pediatric Orthopedic Surgery.

  August 9, 2023

   · 

  5 min read
• Biotech Beach

  Rockley Photonics Advances Development of Its Wearable, Laser-Based Blood Pressure Monitor With Successful Completion of Human Studies

  Rockley Photonics is excited to announce the initial results from two important IRB-approved human studies using a first-generation Alpha prototype of their non-invasive and laser-based cuffless blood pressure monitor.

  August 9, 2023

   · 

  4 min read
• Personalized Medicine Market Report Insight to 2030

  The global personalized medicine market size was exhibited at USD 2.12 trillion in 2021 and it is expected to be worth around USD 5.7 trillion by 2030 with a CAGR of 11.6% from 2022 to 2030.

  August 9, 2023

   · 

  10 min read
• VANFLYTA® (quizartinib) Now Available from Onco360

  Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by Daiichi Sankyo to be a specialty pharmacy partner for VANFLYTA® (quizartinib).

  August 9, 2023

   · 

  3 min read
• Business

  Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results

  Interpace Biosciences, Inc. announced financial results for the second quarter ended June 30, 2023 and provided a business and financial update.

  August 9, 2023

   · 

  11 min read
• Pharm Country

  Oligomerix Publishes Preclinical Data on Novel Small Molecule Therapeutic in Development for Alzheimer’s Disease and Rare Neurodegenerative Diseases

  Oligomerix, Inc. announced today the publication of preclinical data demonstrating that the oral small molecule OLX-07010 inhibits tau aggregation in a model for inherited tauopathies such as progressive supranuclear palsy (PSP) and frontotemporal dementia (FTD).

  August 9, 2023

   · 

  4 min read
• Deals

  Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity

  Carmell Corporation, a regenerative care company announced the successful closing of the previously announced merger with Flagstaff-based Axolotl Biologix, a profitable regenerative medicine company developing products for active soft tissue repair, aesthetics and orthopedic indications.

  August 9, 2023

   · 

  5 min read
• Business

  Surrozen Provides Second Quarter 2023 Financial Results

  Surrozen, Inc., a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, provided second quarter 2023 financial results and corporate and pipeline updates.

  August 9, 2023

   · 

  11 min read
• Business

  Nortech Systems Reports Second Quarter 2023 Results

  Nortech Systems Incorporated (Nasdaq: NSYS) (the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, industrial and defense markets, reported 2023 second quarter results for the period ended June 30, 2023.

  August 9, 2023

   · 

  12 min read
• Business

  BioCardia Reports Second Quarter 2023 Business Highlights and Financial Results

  BioCardia, Inc. reports financial results for the second quarter of 2023 and filed its quarterly report on Form 10-Q for the three and six months ended June 30, 2023 with the Securities and Exchange Commission.

  August 9, 2023

   · 

  16 min read